相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Update and latest advances in antiretroviral therapy
Luis Menendez-Arias et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis
Yerkezhan Amerzhanova et al.
FRONTIERS IN IMMUNOLOGY (2022)
Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
Hager Mohamed et al.
FRONTIERS IN IMMUNOLOGY (2022)
G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)
Sergi Ferre et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species
Xiao L. Chang et al.
PLOS PATHOGENS (2022)
Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status
Fanny Momboisse et al.
ELIFE (2022)
Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5-CCR5 axis
Saida Mukanova et al.
FRONTIERS IN IMMUNOLOGY (2022)
CCL5/CCR5 axis in human diseases and related treatments
Zhen Zeng et al.
GENES & DISEASES (2022)
Risks and benefits of reducing the number of drugs to treat HIV-1 infection
Julen Cadinanos et al.
EXPERT OPINION ON DRUG SAFETY (2021)
mRNA vaccines offer hope for HIV
Lynn Morris
NATURE MEDICINE (2021)
Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers
Ian Michael McGowan et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)
Broadly neutralizing antibodies for HIV-1 prevention and therapy
Boris Julg et al.
SEMINARS IN IMMUNOLOGY (2021)
A Two-Birds-One-Stone Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region
Chao Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor
Celien Jacquemard et al.
VIRUSES-BASEL (2021)
Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5
Hui Zhang et al.
NATURE COMMUNICATIONS (2021)
Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist
Polina Isaikina et al.
SCIENCE ADVANCES (2021)
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Kathryn E. Stephenson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES
John W. McBride et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins
Samuel Jurado et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Molecular Mechanism of HIV-1 Entry
Bing Chen
TRENDS IN MICROBIOLOGY (2019)
Structural basis of coreceptor recognition by HIV-1 envelope spike
Md Munan Shaik et al.
NATURE (2019)
Why and where an HIV cure is needed and how it might be achieved
Thumbi Ndung'u et al.
NATURE (2019)
Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?
Sonia de Castro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Remodeling our concept of chemokine receptor function: From monomers to oligomers
Laura Martinez-Munoz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell Interface
Adel A. Rashad et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers
Massimiliano Secchi et al.
SCIENTIFIC REPORTS (2018)
The Expanding Therapeutic Perspective of CCR5 Blockade
Luca Vangelista et al.
FRONTIERS IN IMMUNOLOGY (2018)
Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist RevealsMechanisms of Chemokine Recognition and Molecular Mimicry by HIV
Yi Zheng et al.
IMMUNITY (2017)
Combination of the CCL5-Derived Peptide R4.0 with Different HIV-1 Blockers Reveals Wide Target Compatibility and Synergic Cobinding to CCR5
Massimiliano Secchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry
Bo Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Resistance to the CCR5 Inhibitor 5P12-RANTES Requires a Difficult Evolution from CCR5 to CXCR4 Coreceptor Use
Rebecca Nedellec et al.
PLOS ONE (2011)
Engineering of Lactobacillus jensenii To Secrete RANTES and a CCR5 Antagonist Analogue as Live HIV-1 Blockers
Luca Vangelista et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Resistance to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance
Rebecca Nedellec et al.
JOURNAL OF VIROLOGY (2010)
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants
Massimiliano Secchi et al.
PROTEIN EXPRESSION AND PURIFICATION (2009)
Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide
Hubert Gaertner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1
Erhard Kopetzki et al.
VIROLOGY JOURNAL (2008)
Steric accessibility of the HIV-1 gp41 N-trimer region
AE Hamburger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Protein design of an HIV-1 entry inhibitor
MJ Root et al.
SCIENCE (2001)